Trial · NCT06016556
Outcomes40
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 40
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants Classified According to Education Level at Index Date | At index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. Here, Overall Number of Participants Analyzed signifies those number of participants who had non-missing values and were evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants Classified According to Employment Status at Index Date | At index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. Here, Overall Number of Participants Analyzed signifies those number of participants who had non-missing values and were evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Height at Index Date | At index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. Here, ''Overall Number of Participants Analyzed'' signifies number of participants who had non-missing values and were evaluable for this outcome measure. | Meters | MEAN |
| PRIMARY | Weight at Index Date | At index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. Here, ''Overall Number of Participants Analyzed'' signifies number of participants who had non-missing values and evaluable for this outcome measure. | Kilograms | MEAN |
| PRIMARY | Body Mass Index (BMI) at Index Date | At index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. Here, ''Overall Number of Participants Analyzed'' signifies number of participants who had non-missing values and evaluable for this outcome measure. | Kg/m^2 | MEAN |
| PRIMARY | Number of Participants Classified According to Smoking Status at Index Date | At index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. Here, Overall Number of Participants Analyzed signifies those number of participants who had non-missing values and were evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants Who Had at Least 1 Pre-existing Comorbidity at Index Date | At index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants Who Had at Least 1 Concomitant Medication for Comorbidities at Index Date | At index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. Here, Overall Number of Participants Analyzed signifies those number of participants who had non-missing values and were evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants With COVID-19 Infection During the Last 6 Months Prior to Index Date | During 6 months prior to index date, information obtained at index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. Here, Overall Number of Participants Analyzed signifies those number of participants who had non-missing values and were evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Duration Between Last COVID-19 Infection and Index Date | From 6 months prior to index date up to index date, information obtained at index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. Here, ''Overall Number of Participants Analyzed'' signifies participants evaluable for this outcome measure. | Months | MEAN |
| PRIMARY | Number of Participants Who Had Previously Received at Least 1 Dose of Any COVID-19 Vaccine | Historic information obtained at index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. Here, Overall Number of Participants Analyzed signifies those number of participants who had non-missing values and were evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants Classified According to the Type of COVID-19 Vaccine Received Previously | Historic information obtained at index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. Here, Overall Number of Participants Analyzed signifies those number of participants who had non-missing values and were evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Duration Between Previous COVID-19 Vaccination Date and Index Date | From date of first COVID-19 vaccination to index date, information obtained at index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. Here, Overall Number of Participants Analyzed signifies those number of participants who had non-missing values and were evaluable for this outcome measure. | Months | MEAN |
| PRIMARY | Number of Participants Classified According to Total Number of Previous COVID-19 Vaccine Doses Taken | Historic information obtained at index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. Here, Overall Number of Participants Analyzed signifies those number of participants who had non-missing values and were evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants Classified According to Dose of Nirmatrelvir/Ritonavir Received at Index Date | At index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants Classified According to Frequency of Dosing of Nirmatrelvir/Ritonavir (PAXLOVIDTM) at Index Date | At index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants Classified According to Dispensed Type of Nirmatrelvir/Ritonavir (PAXLOVIDTM) at Index Date | At index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants Classified According to Medications Used to Treat COVID-19 Infection at Index Date | At index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants Who Were Hospitalized at Index Date | Information obtained at index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants Who Were Hospitalized Due to COVID-19 at Index Date | Information obtained at index date; retrospective data was evaluated during approximately 6 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. Here, ''Overall Number of Participants Analyzed'' signifies participants evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06016556/outcomes